Clinical trial
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal…
NCT00364832 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00364832 |
|---|---|
| Title | A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. |
| Official title | An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Subcutaneous Epoetin Alfa or Beta to Maintenance Treatment With Subcutaneous RO0503821 in Dialysis Patients With Chronic Renal… |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 137 |
| Start date | Oct 1, 2001 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Aug 16, 2006 |
| Last update posted | Dec 20, 2016 |
| Countries | Germany, Italy, Spain, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: